Pfizer, Others Sued By Health Plans Over Copay Coupons

Law360, New York (March 7, 2012, 5:52 PM EST) -- Pfizer Inc., GlaxoSmithKline PLC and six other major drugmakers were sued in class actions under federal racketeering and antitrust laws Wednesday for allegedly subsidizing illegal copayments for brand-name prescription drugs such as Lipitor and Nexium through the promotion of copay coupons.

A coalition of health plans allege that Abbott Laboratories, Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Co., GSK, Merck & Co. Inc., Novartis AG and Pfizer are paying undisclosed kickbacks to privately-insured individuals so that they choose the companies' brand-name drugs instead of less expensive alternatives....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.